Production of the Bakırköy strain of sheeppox vaccine virus in spinner flasks using an alternative method with Cytodex 1 microcarriers on Vero cells Authors: Görkem Çolak, Serdar Uzar, Meral Birbir Published: 2025 ABSTRACT BackgroundSheeppox (SPP) is a highly contagious viral disease that causes significant morbidity and economic losses in small ruminants. Effective control relies on widespread vaccination, yet conventional production methods that utilize monolayer cultures are limited in scalability, making it difficult to meet large-scale vaccine demands. This study aimed to determine optimal and scalable conditions for producing the Bakırköy strain of the sheeppox virus (SPPV) vaccine using Cytodex 1 microcarriers (MCs) in spinner flasks with Vero cells.MethodsVero cells were propagated in serum-supplemented medium, and cell growth, viability, glucose utilization, and metabolite accumulation were monitored during the expansion phase. In both systems, cells were infected with the Bakırköy strain of SPPV vaccine at multiplicities of infection (MOIs) of 0.1 and 1, and viral titers, cell viability, and metabolite levels were evaluated post-infection.ResultsSpinner flask cultures supported higher cell densities and maintained cell viability longer than T-flask cultures. Virus replication was more efficient under dynamic conditions, resulting in higher peak titers and an extended productive phase. Metabolite accumulation (lactate and ammonia) did not adversely affect virus yield until they reached critical thresholds.ConclusionsThese findings highlight the importance of metabolite control in optimizing SPPV vaccine production. They also demonstrate that Cytodex 1 microcarrier (MC)-based spinner flask cultures offer a robust and scalable alternative to conventional methods. This approach enables prolonged production, higher viral yields, and greater potential for large-scale vaccine manufacturing. Introduction Sheeppox virus (SPPV) is a highly contagious viral pathogen of sheep, causing significant economic losses in endemic regions [1]. SPPV, belonging to the family Poxviridae and genus Capripoxvirus, is an enveloped, double-stranded DNA virus that causes sheeppox (SPP) in sheep [1–3]. SPPV was first detected in Central Asia and then spread to African countries [4, 5]. SPP remains endemic in Türkiye and continues to pose an economic and veterinary threat to small ruminant populations [1, 6]. In recent years, outbreaks have also been reported in parts of Eastern and Southern Europe, indicating a potential risk of wider geographic spread [5–14]. Vaccination is highly effective in preventing SPP outbreaks in endemic regions. Both attenuated live and inactivated Capripoxvirus vaccines have been used to protect animals against these diseases [1]. Currently, only live attenuated vaccines are used against SPPV. Strains such as Kenyan isolates and RM65 have been widely applied in the Middle East to control the disease, while the Bakırköy strain is routinely used in Türkiye for the prevention of SPPV [6]. Although primary lamb kidney and primary lamb testis cells have been used to isolate and propagate SPPV, their need for continuous fresh preparation, susceptibility to contamination, and batch-to-batch variability limit their practical utility [5, 15–18]. To overcome these limitations, several continuous cell lines, including African green monkey kidney (Vero) [5, 19–21], embryonic sheep skin (ESH-L) [1, 5, 22], Madin–Darby bovine kidney (MDBK) [5, 23, 24], and lamb testis (OA3.Ts) cells [5, 25] have been used for SPPV production. Vero cells have also been successfully adapted to suspension culture systems and used to produce various viruses [26–31]. Vero cells, which are surface-dependent, are among the cell lines in which SPPV can replicate [5, 19–21]. These cells can be cultivated in spinner flasks [32, 33] or in bioreactors using microcarriers (MCs) [30, 33–35]. A variety of viruses—including poliovirus, rabies virus, foot-and-mouth disease virus, Avian orthoavulavirus 1 (Newcastle disease virus), recombinant vesicular stomatitis Indiana virus (rVSV), and Zaire ebolavirus (ZEBOV)—have been produced in Vero cells using MCs, which offer numerous advantages over conventional production methods [32, 35–39]. Advantages include the use of microcarrier (MC)-based cell culture systems for large-scale production of viral vaccines [38] and for use in stirred bioreactors [40]. Various viruses have been successfully produced in Vero cells using MCs [32–35, 39]. Scalable MC-based systems are therefore increasingly important for modern vaccine production, particularly for viruses such as SPPV that require surface-dependent cell systems. From a bioprocessing standpoint, MC-based dynamic cultures offer improved scalability and process control compared with traditional monolayer systems. They are also consistent with modern trends in vaccine biomanufacturing. However, the Bakırköy strain of SPPV vaccine has not yet been produced in Vero cell culture using Cytodex 1 MCs, and this approach has not been compared with conventional T-flask cultures. To address this gap, the present study evaluated Cytodex 1 MC-based spinner flask cultures as a scalable alternative for producing the Bakırköy strain of SPPV vaccine. Their performance was also compared with that of conventional monolayer cultures. We also examined how key biochemical parameters (glucose, lactate, and ammonia) influenced cell growth and virus replication, providing practical insights that may support future process improvements. Materials and methods Materials The Vero cell line (ATCC, CCL-81), kept in liquid nitrogen at − 196 °C, was obtained from Pendik Veterinary Control Institute Cell Bank (Türkiye). The Bakırköy strain of SPPV vaccine, stored at − 80 °C in the Viral Vaccines Production Laboratory of the same institute, was used in this study. The strain was originally isolated from a clinical case in Istanbul and attenuated through serial passages in lamb kidney and Vero cells [41]. Dulbecco’s Modified Eagle Medium (DMEM, high-glucose; Capricorn Scientific, Germany) supplemented with heat-inactivated fetal bovine serum (FBS; Gibco, U.S.A.), L-glutamine (Gibco, U.S.A.), penicillin G, and streptomycin sulphate (PanReac AppliChem, Germany) was used for cell culture. Cytodex 1 MCs (Cytiva, Sweden) were used for MC-based cultures. All other chemicals were of analytical grade and purchased from standard commercial suppliers. Methods Preparation of MCs Cytodex 1 MCs were prepared and sterilized according to the manufacturer’s instructions [42]. Briefly, MCs (3 g/L) were hydrated in phosphate-buffered saline (PBS) without Ca2 +/Mg2 + for at least 3 h at room temperature, washed, and autoclaved at 115 °C for 15 min. After sterilization, the MCs were rinsed with warm high-glucose DMEM. Growth of Vero cells in static flasks and MCs in spinner flasks Vero cells were cultured in T-75 tissue culture flasks (Greiner Bio-One, Austria) using high-glucose DMEM supplemented with 10% FBS, penicillin G (100 U/mL), streptomycin sulphate (100 µg/mL), and L-glutamine (4 mM). Cells were incubated at 37 °C in a humidified incubator with 5% CO2. When the cultures reached 90% confluence after 72 h, cells were passaged to T-175 flasks (Greiner Bio-One, Austria) using standard trypsinization [43]. Vero cells from T-175 flasks were transferred to 1 L spinner flasks (Corning, U.S.A.) containing 400 mL of high-glucose DMEM supplemented with 10% FBS, penicillinG (100 U/mL), streptomycin sulphate (100 µg/mL), L-glutamine (4 mM), and 1.2 g Cytodex1 MCs. Cells were cultured at 37 °C in a humidified shaker incubator (30rpm) with 5% CO2 for 192 h. To promote cell attachment, shaking was paused four times at 20-minute intervals during the initial incubation period. Samples were collected before incubation and at 24 h intervals to assess cell viability, specific growth rate, doubling time, and glucose and metabolite concentrations (lactate, ammonia). Additionally, 100 µL aliquots were examined under an inverted microscope at 24 h intervals to monitor cell attachment and density on MCs. SPPV vaccine production in the conventional T-flask cultures and MC-based spinner flask cultures The Bakırköy strain of the SPPV vaccine was produced using both the conventional T-flask monolayer method and the Cytodex 1 MC-based spinner flask system for comparative evaluation. Vero cells were cultured for 192 h until reaching optimal density, washed with PBS, and infected with the Bakırköy strain of SPPV vaccine at multiplicities of infection (MOIs) of 0.1 and 1. For spinner flask cultures, agitation was stopped before infection to allow MCs to settle for 15 min, after which the supernatant was carefully decanted. Virus adsorption was carried out for 1 h at 37 °C in both cultures, followed by removal of the inoculum. Cultures were then maintained in high-glucose DMEM supplemented with 2% FBS and 4 mM L-glutamine at 37 °C in a humidified atmosphere with 5% CO2 for up to 312 h. Spinner flask cultures were agitated at 30 rpm throughout the incubation period, whereas T-flask cultures were maintained under static conditions. During the 312 h incubation period, samples were collected at 24 h intervals from both cultures to monitor cell viability; concentrations of glucose, lactate, and ammonia; and culture pH (measured with a pH meter). Microscopic examination was performed daily to assess cell morphology and cytopathic effects (CPE). Virus‑containing supernatants were centrifuged at 3000rpm for 15 min at 4 °C to remove cellular debris and stored at − 80 °C for titration. Cell counting in T-flask cultures and spinner flask cultures Viable Vero cell numbers were measured throughout the cell growth phase and SPPV vaccine production phase across all culture conditions (spinner flasks, T-flasks, and controls). Cell viability was assessed by trypan blue (Elabscience, U.S.A.) exclusion [0.2% (w/v) in PBS], and viable cells were counted with a hemacytometer (Heinz Herenz, Germany) [44, 45]. The doubling time (td) and specific growth rate (μ) of Vero cells were calculated using samples collected during the cell growth phase across all culture conditions, according to the following equations [35, 45, 46]: 1\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\matrix{ {} & { \mu = {{{\rm{ln}}\left( {{X_n}} \right) - {\rm{ln}}\left( {{X_{n - 1}}} \right)} \over {{t_n} - {t_{n - 1}}}}} & {} & {{\rm{}}} \cr } $$\end{document}2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\matrix{ {} & { {t_d} = {{{\rm{ln}}\left( 2 \right)} \over \mu }} & {} & {{\rm{}}} \cr } $$\end{document} In Eq. (1), μ represents the specific growth rate, X is the viable cell concentration (cells/mL), t is the sampling time (h), and the subscripts n and n–1 denote two successive sampling points. In Eq. (2), td represents the doubling time. Analyses of glucose and metabolites (lactate and ammonia) concentrations Glucose concentrations were measured spectrophotometrically using a biochemical analyzer (BioSystems, Spain). Lactate concentrations were determined with Elabscience® L-Lactic Acid (LA) Colorimetric Assay Kit (Elabscience, U.S.A.) according to the manufacturer’s instructions [47]. Ammonia concentrations were measured with the EnzyChrom TMAmmonia/Ammonium Assay Kit (BioAssay Systems, U.S.A.) following the manufacturer’s instructions [48]. Titration test of SPPV vaccine Samples of the SPPV vaccine were titrated in 96-well cell culture plates (Greiner Bio-One, Austria) on Vero cells. Serial 10-fold dilutions (10−1 to 10−6) of the SPPV vaccine samples were prepared and added to wells containing 3 × 104 cells per well. Each dilution was performed in duplicate, with eight wells per dilution per replicate. Virus and cell control wells were included. The plates were incubated at 37 °C for seven days in a humidified incubator with 5% CO2. During the incubation period, cells were examined every 24 h under an inverted microscope to identify CPE. The log value of the 50% tissue culture infectious dose (TCID50) was determined from the number of positive CPE observations using the Spearman—Kärber method [46, 49, 50]. Sterility test Sterility testing was performed according to the European Pharmacopoeia [51]. Samples were collected at 0 h, 72 h, and 192 h (pre-infection) during the cell growth phase, and at 48 h post-infection (hpi), 168 hpi, 240 hpi, and 312 hpi. At each time point, 1 mL of culture medium was aseptically collected from all cultures and inoculated into Fluid Thioglycollate Medium (FTM) and Soybean Casein Digest Medium, commonly known as Tryptic Soy Broth (TSB) (Oxoid, U.K.). While TSB cultures were incubated at 20–25 °C for 14 days, FTM cultures were incubated at 30–35 °C for the same duration. Statistical analysis All experiments, including conventional T-flask cultures and MC-based spinner flask cultures, were performed in three independent biological replicates for each condition: 0.1 multiplicity of infection (MOI), 1 MOI, and uninfected control. Viable cell density, virus titers, glucose concentrations, and the metabolite levels (lactate and ammonia) were reported as mean ± standard deviation (SD). Statistical analyses were carried out using IBM Statistical Package for the Social Sciences (SPSS) Statistics (version 27.0.1.0). For pairwise comparisons, the unpaired Student’s t–test was used for normally distributed data, and the Mann–Whitney U test for non‑parametric data. For comparisons among multiple groups or time points, the Games–Howell post hoc test was applied to account for unequal variances. Pearson correlation and linear regression analyses were used to assess relationships among virus titers, viable cell counts, and cell viability (%). A p‑value < 0.05 was considered statistically significant. Graphs illustrating time-dependent changes in cell viability, virus titers, and metabolite concentrations for each culture were generated using GraphPad Prism version 10.4.2 (GraphPad Software, U.S.A.). Results Growth of vero cells in MC-based spinner flasks and conventional T-flask cultures Vero cells were cultured in MC-based spinner flasks and conventional T-flasks to compare cell growth profiles over 192 h. The initial mean viable cell densities were comparable between the two culture systems. Viable and total Vero cell numbers are presented in Fig. 1A, and corresponding μ and td values are summarized in Table 1. In spinner flask cultures, Viable cell density increased steadily throughout the 192 h period, reaching its maximum at the end of the incubation (Fig. 1A). The highest μ and shortest td were observed at 72 h (Table 1). T-flask cultures exhibited a more rapid early increase, reaching peak density at 168 h (Fig. 1A), with the highest μ and shortest td at 48 h (Table 1). After 168 h, viable cell numbers declined slightly due to contact inhibition, whereas spinner flask cultures maintained growth, resulting in comparable viable cell counts between the systems at 192 h.Fig. 1A) Mean viable and total Vero cell counts in monolayer (T-flasks) and spinner flask cultures (Cytodex 1 MCs) over a 192-h incubation. Error bars indicate the variability among replicates. B) Microscopic observations of Vero cells in spinner flask and T-flask cultures at 0 h, 96 h, and 192 h. Images were taken under an inverted light microscope (40×) without staining. Scale bar: 200 µmTable 1Specific growth rates (μ) and doubling times (td) of Vero cells grown in spinner flasks and monolayer (T-flasks) cultures during the cell growth phaseTime (h)MC μ (h−1)MC td (h)T-Flask μ (h−)T-Flask td (h)0----24−0.0268ng*0.017639.34480.024728.050.048114.41720.050613.700.027025.64960.011361.170.0018374.241200.0038182.860.0017390.881440.007493.100.0017407.511680.008878.400.007691.241920.009374.55−0.0119ng* A) Mean viable and total Vero cell counts in monolayer (T-flasks) and spinner flask cultures (Cytodex 1 MCs) over a 192-h incubation. Error bars indicate the variability among replicates. B) Microscopic observations of Vero cells in spinner flask and T-flask cultures at 0 h, 96 h, and 192 h. Images were taken under an inverted light microscope (40×) without staining. Scale bar: 200 µm Table 1Specific growth rates (μ) and doubling times (td) of Vero cells grown in spinner flasks and monolayer (T-flasks) cultures during the cell growth phaseTime (h)MC μ (h−1)MC td (h)T-Flask μ (h−)T-Flask td (h)0----24−0.0268ng*0.017639.34480.024728.050.048114.41720.050613.700.027025.64960.011361.170.0018374.241200.0038182.860.0017390.881440.007493.100.0017407.511680.008878.400.007691.241920.009374.55−0.0119ng* Specific growth rates (μ) and doubling times (td) of Vero cells grown in spinner flasks and monolayer (T-flasks) cultures during the cell growth phase Significant differences in viable cell counts were detected between 24 and 168 h (p < 0.05), with higher values in T-flask cultures; however, no significant differences were observed at 0 and 192 h. Inverted microscope images of Vero cells were taken every 96 h until the end of the 192 h incubation (Fig. 1B). In spinner flask cultures, cells began attaching to MCs after 48 h, with attachment steadily increasing and reaching maximal coverage at 192 h (Fig. 1B). In T-flasks, confluency increased visibly over time, reaching near-complete monolayer formation after 144 h. These observations were consistent with the viable cell count data shown in Fig. 1A. Overall, spinner flask cultures supported stable, prolonged growth of Vero cells. In contrast, T-flask cultures showed faster but limited expansion due to earlier confluence. SPPV vaccine production and viral titer analysis in spinner flasks and T-flasks under different MOIs After 192 h of cell growth, Vero cells were infected with the attenuated SPPV vaccine at two MOIs (0.1 and 1). The first sample (1 hpi) was collected immediately after the 1 h adsorption period, and uninfected controls were maintained to assess baseline cell viability and metabolic activity. Following infection, viable cell density declined in both culture systems (Fig. 2A–B). In spinner flask cultures, virus titers increased and reached their maximum at 240 hpi (Fig. 3A). In T-flask cultures, peak titers occurred earlier—at 144 hpi for 0.1 MOI and 168 hpi for 1 MOI (Fig. 3B). At the final time point (312 hpi), both systems showed a moderate decline in viral titers and maintained higher titers at 1 MOI than at 0.1 MOI. Fig. 2A) Mean viable cell counts in MC-based spinner flask cultures infected with the attenuated SPPV vaccine at MOIs of 0.1 and 1, along with the uninfected control. B) Mean viable cell counts in T-flask cultures infected at MOIs of 0.1 and 1, along with the uninfected control. Error bars indicate variability among replicatesFig. 3Mean virus titers of the bakırköy strain of SPPV vaccine over 312 h post-infection. A) Virus titers in T-flask cultures infected at MOIs of 0.1 and 1. B) Virus titers in Cytodex 1 MC-based spinner flask cultures infected at MOIs of 0.1 and 1. Error bars indicate variability among replicates A) Mean viable cell counts in MC-based spinner flask cultures infected with the attenuated SPPV vaccine at MOIs of 0.1 and 1, along with the uninfected control. B) Mean viable cell counts in T-flask cultures infected at MOIs of 0.1 and 1, along with the uninfected control. Error bars indicate variability among replicates Mean virus titers of the bakırköy strain of SPPV vaccine over 312 h post-infection. A) Virus titers in T-flask cultures infected at MOIs of 0.1 and 1. B) Virus titers in Cytodex 1 MC-based spinner flask cultures infected at MOIs of 0.1 and 1. Error bars indicate variability among replicates Mann–Whitney U tests were used to compare viable cell density (cells/mL) among the 0.1 MOI, 1 MOI, and uninfected control groups in both spinner flasks and T-flasks. In spinner flasks, viability did not differ significantly between 0.1 and 1 MOI (p = 0.452) or between 0.1 MOI and controls (p = 0.265), but was reduced at 1 MOI compared to controls (p = 0.049). In T-flask cultures, significant differences were observed among all groups (p < 0.05), with the greatest decline in viability at 1 MOI relative to controls (p < 0.001). The Games–Howell post hoc test showed significant differences in viral titers among the 0.1 MOI, 1 MOI, and uninfected groups in spinner flasks (p < 0.001), driven by the higher titers observed at 1 MOI. No significant differences were found between corresponding MOI levels in spinner and T-flask cultures (0.1 MOI: p = 0.969; 1 MOI: p = 0.979) or between uninfected controls (p = 1.000). Microscopic observations (Fig. 4) revealed time-dependent CPE and cell detachment patterns in both culture systems during SPPV production. In spinner flasks, cell detachment from Cytodex 1 MCs began at 120 hpi for 0.1 MOI and 72 hpi for 1 MOI. Likewise, in T-flask cultures, CPE appeared at the corresponding time points for each MOI (72 hpi for 1 MOI and 120 hpi for 0.1 MOI). Overall, viral replication efficiency was mainly determined by the MOI, with both culture systems showing comparable infection kinetics.Fig. 4Microscopic observations of Cytodex 1 MC loading during virus production in spinner flasks and morphological changes in T-flask cultures. Vero cells were infected with the bakırköy strain of SPPV vaccine at MOIs of 0.1 and 1. Images were taken under an inverted light microscope without staining at 40× magnification at 24 hpi, 72 hpi, 120 hpi, 168 hpi, 216 hpi, 264 hpi, and 312 hpi – scale bar: 200 µm Microscopic observations of Cytodex 1 MC loading during virus production in spinner flasks and morphological changes in T-flask cultures. Vero cells were infected with the bakırköy strain of SPPV vaccine at MOIs of 0.1 and 1. Images were taken under an inverted light microscope without staining at 40× magnification at 24 hpi, 72 hpi, 120 hpi, 168 hpi, 216 hpi, 264 hpi, and 312 hpi – scale bar: 200 µm Glucose, lactate, and ammonia concentrations in the cell growth phase In spinner flask cultures, glucose concentration decreased progressively after 24 h, reaching 0.04 mM by 192 h, while lactate and ammonia accumulated to 37.8 ± 0.34 mM and 5.27 ± 0.05 mM, respectively (Fig. 5A–C). The highest glucose consumption and μ occurred around 72 h, followed by a continuous increase in metabolite accumulation until the end of the growth phase. Fig. 5Glucose (A), lactate (B), and ammonia (C) concentrations (mM) in culture supernatants during the 192 h vero cell growth phase in spinner flask and T-flask cultures. Data represent the mean ± SD from three independent biological replicates Glucose (A), lactate (B), and ammonia (C) concentrations (mM) in culture supernatants during the 192 h vero cell growth phase in spinner flask and T-flask cultures. Data represent the mean ± SD from three independent biological replicates In T-flask cultures, metabolite trends followed a similar pattern, with glucose depleted by 192 h and corresponding increases in lactate and ammonia (Fig. 5A–C). As in spinner cultures, the highest glucose consumption also occurred around 72 h. These parallel profiles indicate active cell proliferation in both systems and the expected accumulation of metabolic by-products as cultures approached confluence. The Mann–Whitney U test showed no significant differences in glucose, lactate, or ammonia concentrations between spinner flask and T-flask cultures during the growth phase (p > 0.05). Glucose decreased in both cultures due to metabolic activity, while lactate and ammonia continued to accumulate, consistent with cellular metabolism of glucose and L-glutamine. Glucose, lactate, and ammonia concentrations in SPPV vaccine production At the start of the production phase, glucose concentrations were similar in spinner flask and T-flask cultures at both MOIs. Following infection, glucose concentrations decreased markedly in both cultures, and glucose consumption was substantially higher during the production phase than during the cell growth phase, reflecting the increased metabolic demand associated with viral replication. Lactate accumulated to approximately 40–45 mM, while ammonia increased to 6–7 mM by the end of the 312 hpi incubation in both cultures (Fig. 6A–D). Lactate and ammonia accumulation were slightly more pronounced in T-flask cultures, particularly at 1 MOI, likely due to reduced oxygen transfer and nutrient diffusion under static conditions. Uninfected controls displayed typical profiles of glucose depletion, lactate accumulation, and gradual increases in ammonia (Fig. 6A–D). Taken together, these results indicate that both culture systems exhibited comparable metabolic responses to SPPV vaccine infection, although the spinner flask provided a more balanced metabolic environment during prolonged incubation. Fig. 6Glucose, lactate, and ammonia concentrations (mM) in culture supernatants over 312 h post-infection. A-B) Spinner flask cultures infected at 0.1 and 1 MOI, respectively. C-D) T-flask cultures infected at 0.1 and 1 MOI, respectively. Uninfected controls are shown in each panel. Data represent mean ± SD from three biological replicates Glucose, lactate, and ammonia concentrations (mM) in culture supernatants over 312 h post-infection. A-B) Spinner flask cultures infected at 0.1 and 1 MOI, respectively. C-D) T-flask cultures infected at 0.1 and 1 MOI, respectively. Uninfected controls are shown in each panel. Data represent mean ± SD from three biological replicates Relationships between SPPV vaccine virus titers, cell density, and viability Peak virus titers and corresponding cellular–metabolic parameters were analyzed to evaluate their combined effect on SPPV vaccine production in spinner flask and T-flask cultures. In spinner flask cultures, peak virus titers were reached at 240 hpi (Fig. 3A), coinciding with elevated lactate (~40–44 mM) and ammonia (~4.5–5 mM) concentrations and lower viable cell density (Fig. 7B). In T-flask cultures, peak virus titers were achieved earlier (Fig. 3B), at time points when metabolite concentrations were lower and viable cell densities higher compared with spinner flask cultures at their respective peaks (Fig. 7D).Fig. 7Virus titers, cell viability (%), and viable cell counts (cells/mL) in Vero cells over 312 h post-infection. A-B) Spinner flask cultures infected at 0.1 and 1 MOI, respectively. C-D) T-flask cultures infected at 0.1 and 1 MOI, respectively. Data are shown as mean ± SD from three biological replicates Virus titers, cell viability (%), and viable cell counts (cells/mL) in Vero cells over 312 h post-infection. A-B) Spinner flask cultures infected at 0.1 and 1 MOI, respectively. C-D) T-flask cultures infected at 0.1 and 1 MOI, respectively. Data are shown as mean ± SD from three biological replicates Viral titers gradually declined after their peaks, corresponding with increasing lactate and ammonia accumulation and reduced cell viability in both cultures. Spinner flask cultures maintained higher viable cell densities and sustained productivity for a longer period. At 312 hpi, cell viability was approximately 50–60% in spinner flasks and 40–50% in T-flasks, with more rapid decline at 1 MOI (Fig. 7A, C). During the 312 h virus production phase without medium exchange, spinner flask cultures showed a more gradual decline in cell viability compared with T-flask cultures. Consistently, in T-flask cultures—especially at 1 MOI—microscopy revealed clear cell detachment after 288 hpi, consistent with the sharper decline in cell viability. Overall, elevated metabolite accumulation and declining cell viability were associated with reduced viral titers. Spinner flask cultures supported a longer and more balanced viral production phase compared with static T-flask cultures. In spinner flask cultures, virus titers showed a negative correlation with both cell viability and viable cell count, with the correlation significant for viable cell count at 0.1 MOI (p < 0.001, R2 = 0.70) but weaker at 1 MOI (R2 = 0.44). In T-flask cultures, no significant correlation was found at 0.1 MOI (p = 0.17). However, at 1 MOI, both parameters correlated significantly with virus titer (R2 = 0.44), indicating a stronger dependence on cell-related factors at higher infection levels. Sterility test Sterility was assessed at selected time points during both the cell growth (0, 72, and 192 h) and virus production phases (48, 168, 240, and 312 hpi) [51]. All procedures were conducted under sterile conditions, and no contamination was detected. Discussion This is the first study to produce the Bakırköy strain of SPPV vaccine in Vero cells using Cytodex 1 MCs in spinner flasks. Previous studies relied on monolayer cultures such as T-flasks or roller bottles with MDBK, lamb kidney cells, and Vero cells [41, 52]. MC-based systems have also been used to produce other strains of SPPV, including RM65, and have been widely applied for the production of various other viruses in Vero cells [32, 33, 35, 46, 53–56]. In the present study, MC-based spinner flask cultures and T-flask cultures were directly compared to evaluate differences in Vero cell growth, virus titers, and metabolite accumulation. T-flask cultures reached higher peak cell densities at earlier time points. In contrast, spinner flask cultures supported more gradual but sustained proliferation. This difference likely reflects the improved nutrient and oxygen distribution provided by agitation in spinner flasks compared with the limited surface area of static T-flasks. Although the maximum Vero cell density achieved in this study was lower than that reported by Trabelsi et al. (2014), the specific growth rate was higher, indicating efficient cell proliferation under spinner flask conditions [46]. Similarly, studies using stirred-tank bioreactors have reported comparable Vero cell expansion kinetics under similar DMEM-based culture conditions [35]. T-flask cultures reached peak virus titers earlier. In contrast, spinner flask cultures achieved higher maximum levels at later time points (Fig. 3A, B), reflecting extended viral replication under dynamic conditions. Comparable titers of the Bakırköy strain have also been reported in MDBK and Vero monolayer cultures [41, 52]. In contrast, Trabelsi et al. (2014) produced the RM65 strain of SPPV in spinner flasks at much lower MOIs and obtained lower virus titers [46], highlighting the impact of strain differences and infection parameters. Several other viruses have also been produced in Vero cells using Cytodex 1 MCs within spinner flasks or bioreactor systems [26, 27, 29, 30, 53, 54, 56]. However, cross-study comparisons remain limited due to differences in virus biology, attenuation levels, MOI values, and bioprocess parameters. Overall, our findings highlight that viral strain characteristics and culture configuration are major determinants of production efficiency in MC-based systems. Importantly, virus titers in both cultures were above the minimum titer recommended by the World Organisation for Animal Health for SPPV vaccines (4.5 log10 TCID50/mL) [1]. From a bioprocess perspective, the prolonged productive window observed in spinner flask cultures is particularly advantageous, as it allows extended virus accumulation without the need to operate multiple vessels in parallel, thereby improving overall process efficiency and scalability. Glucose concentrations decreased steadily in both culture systems during the 192-h growth phase as Vero cell proliferation increased, consistent with previous reports [27, 31, 46, 55]. During the virus production phase, no medium exchange was performed, unlike other studies that included medium replacement or glucose supplementation [27, 31, 46, 57]. Glucose concentrations in both culture systems dropped below 1 g/L early after infection, yet this decline did not adversely affect virus titers, consistent with previous reports [32, 33]. Lactate and ammonia increased in both systems during the growth and production phases. This pattern reflects high metabolic activity. Despite lactate and ammonia reaching high levels, these elevated metabolite concentrations did not markedly inhibit viral replication, consistent with previous findings in Vero cell–based virus production [33]. Uninfected controls showed lower metabolite levels. This finding indicates that infection contributed to ammonia formation, in agreement with earlier observations [31]. Although Paillet et al. (2009) reported lower ammonia accumulation [27], this likely reflects differences in the medium formulation and glutamine supplementation. Variations in ammonia accumulation at different MOI values reported in earlier studies further support the association between infection intensity and nitrogen by-product formation [58]. In both systems, peak viral titers occurred when metabolite concentrations were already high, and titers declined only after these levels increased further. Overall, these results indicate that lactate and ammonia accumulation influenced—but did not solely determine—viral productivity, underscoring the importance of metabolic control for optimizing SPPV vaccine production in MC-based cultures. Conventional T-flask cultures require multiple vessels, increasing labor, time, and space demands [59]. In contrast, spinner flasks with Cytodex 1 MCs provide a larger surface area for cell attachment and better nutrient distribution, supporting more efficient virus production [60]. In our study, the spinner flask system achieved approximately threefold higher SPPV vaccine titers than T-flask cultures, while simplifying the overall production process. Metabolic regulation plays a critical role in SPPV vaccine productivity. The simultaneous increase in lactate and ammonia with declining virus titers highlights the importance of controlling nutrient availability and by-product accumulation for effective bioprocess performance. Strategies such as partial medium exchange, controlled feeding, pH regulation, and optimized glucose–glutamine supplementation may help maintain metabolic balance and enhance overall viral yield. The main limitation of this study was the absence of medium exchange during the extended virus production phase. This likely contributed to metabolite accumulation and the gradual decline in cell viability and viral titers. Additionally, spinner flasks lack active control over dissolved oxygen, which influences Vero cell physiology and viral replication. The process was also evaluated using a single MC type and a serum-containing medium. Future studies should therefore explore alternative MCs, serum-free formulations, and the integration of this system into fed-batch or perfusion bioreactors to enable tighter process control and support sustained, large-scale production. Overall, Cytodex 1 MC-based spinner flask cultures provide a scalable, practical platform for manufacturing SPPV vaccine (Bakırköy strain), with clear opportunities for further bioprocess optimization.